These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32101057)

  • 41. Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis.
    Berney D; Cheng L
    Histopathology; 2012 Jan; 60(1):1-3. PubMed ID: 22212074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer.
    Yu JJ; Yan T
    Aging Male; 2010 Sep; 13(3):159-65. PubMed ID: 20136572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
    Manley S; Mucci NR; De Marzo AM; Rubin MA
    Am J Pathol; 2001 Sep; 159(3):837-43. PubMed ID: 11549576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemistry as a Practical Tool in Molecular Pathology.
    Sheffield BS
    Arch Pathol Lab Med; 2016 Aug; 140(8):766-9. PubMed ID: 27472235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of the number of biopsy specimens from the prostate gland for adequate clinical appraisal of neoplasia].
    Iremashvili VV; Chepurov AK; Emberton M; Vladimirov VG; Zarinskaia SA; Kobaladze KM
    Vopr Onkol; 2010; 56(4):482-6. PubMed ID: 20968031
    [No Abstract]   [Full Text] [Related]  

  • 47. A concise update on prostate pathology.
    Xu W; Zhou M
    Cesk Patol; 2014; 50(4):120-8. PubMed ID: 25418898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Benign mimickers of prostatic carcinoma on needle biopsy and transurethral resection specimens].
    Zhao M; Li C; Teng X
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):781-5. PubMed ID: 25582263
    [No Abstract]   [Full Text] [Related]  

  • 49. [Local anesthesia for biopsy of the prostate].
    Iremashvili VV; Chepurov AK; Vladimirov VG; Zarinskaia SA; Kobaladze KM
    Vopr Onkol; 2010; 56(4):477-81. PubMed ID: 20968030
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
    Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of frozen section in genitourinary pathology.
    Shen SS; Truong LD; Ro JY; Ayala AG
    Pathology; 2012 Aug; 44(5):427-33. PubMed ID: 22772345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidental prostatic cancer: repeat TURP or biopsy?
    Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP
    Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular pathology--translating research into clinical practice: an expanding frontier in surgical oncology.
    Nordberg ML
    Surg Oncol Clin N Am; 2008 Apr; 17(2):303-21, viii. PubMed ID: 18375354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.
    O'Brien BA; Cohen RJ; Wheeler TM; Moorin RE
    BJU Int; 2011 Feb; 107(3):389-95. PubMed ID: 20707795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leveraging digital pathology for molecular testing.
    Pantanowitz L
    Cancer Cytopathol; 2018 Dec; 126(12):965-966. PubMed ID: 30317698
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of the transurethral resection in the cancer of the prostate.
    Vicente J; Chéchile G
    Prog Clin Biol Res; 1987; 243B():283-8. PubMed ID: 3659026
    [No Abstract]   [Full Text] [Related]  

  • 57. Ectopic Pacinian Corpuscle in the Prostate.
    Pai SA
    Int J Surg Pathol; 2017 Oct; 25(7):609-610. PubMed ID: 28420304
    [No Abstract]   [Full Text] [Related]  

  • 58. Solitary fibrous tumor of the prostate: a case report and 5-year follow-up.
    Liu YT; Song FX; Xiang L; Chang H
    Asian J Androl; 2019; 21(4):421-422. PubMed ID: 30950411
    [No Abstract]   [Full Text] [Related]  

  • 59. Undergrading of prostate cancer biopsies: a paradox inherent in all biologic bivariate distributions.
    Gleason DF
    Urology; 1996 Mar; 47(3):289-91. PubMed ID: 8633390
    [No Abstract]   [Full Text] [Related]  

  • 60. Intraductal Carcinoma of the Prostate.
    Humphrey PA
    J Urol; 2015 Nov; 194(5):1434-5. PubMed ID: 26291925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.